Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347886 | PMC |
| http://dx.doi.org/10.1111/jdv.18211 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characteristics of Patients with Adult-Onset Dermatomyositis at 2 Tertiary Care Centres in Ontario, Canada.
J Cutan Med Surg
November 2024
Michael G. DeGroote School of Medicine, Hamilton, ON, Canada.
Dermatomyositis (DM) is an idiopathic inflammatory myopathy characterized by progressive muscle weakness and distinctive cutaneous findings. The exact incidence and prevalence of DM in the general population is largely unknown, and data on demographic and clinical features in patients in Canada are lacking. This study aimed to comprehensively evaluate the patients with DM in Southwestern Ontario, Canada.
View Article and Find Full Text PDFProfile of patients with Juvenile Dermatomyositis and Anti-MDA5 autoantibodies.
Pediatr Res
September 2024
Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Background: Anti-MDA5 autoantibody-positive dermatomyositis (MDA5-DM) is associated with clinically amyopathic forms and rapidly progressive interstitial lung disease (ILD); however, data in children are limited. In this study, we described our cohort of anti-MDA5-positive juvenile DM (MDA5-JDM) from a tertiary care center in North India.
Methods: We performed a retrospective analysis of children with MDA5-JDM who were diagnosed and followed up at our center and compared them with our anti-MDA5-negative cohort.
A 72-year-old man with acute lung injury and anti-melanoma differentiation-associated gene 5 antibody: A case report.
Respir Med Case Rep
August 2024
Department of Medicine, Jefferson Einstein Hospital, Philadelphia, PA, USA.
Anti-melanoma differentiation-associated gene 5 antibody (anti-MDA-5 Ab) is associated with amyopathic dermatomyositis (DM). These patients are particularly at high-risk for developing acute and rapidly progressive interstitial lung disease (ILD). Given the lack of muscle-related symptoms, along with its sudden onset and rapid clinical progression, the diagnosis of anti-MDA-5 Ab + ILD represents a challenge for clinicians.
View Article and Find Full Text PDFPostpartum onset anti-MDA5 antibody-positive clinically amyopathic dermatomyositis; case-based review of perinatal onset anti-MDA5 antibody-positive dermatomyositis.
Rheumatol Int
October 2024
Department of Rheumatology, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Article Synopsis
- Anti-MDA5 antibody positive clinically amyopathic dermatomyositis (CADM) is a rare inflammatory muscle disease mainly affecting the lungs and showing minimal muscle involvement.
- Cases occurring during or after pregnancy are infrequent but can lead to significant complications and severe disease progression.
- A recent case study and review of similar cases highlighted varying disease severity, emphasizing the need for more research to improve treatment approaches and develop better prediction tools for these patients.
Coexistence of anti-KS and anti-TIF1-γ antibodies in clinically amyopathic dermatomyositis presenting with rapid progression of interstitial lung disease.
Mod Rheumatol Case Rep
January 2025
Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan.
Polymyositis/dermatomyositis (DM) is an idiopathic inflammatory myopathy manifesting mainly as symmetrical proximal muscle weakness and/or typical cutaneous features due to autoimmune mechanisms. Clinically amyopathic dermatomyositis (CADM) is a subset of DM that exhibits only the typical cutaneous features without any clinical muscle symptoms. Several autoantibodies have been found specifically in patients with polymyositis/DM, including CADM patients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!